Intellia Therapeutics NTLA
NASDAQ NTLA
$11.41 +0.24 (+2.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Intellia Therapeutics (NTLA) Return on Assets [ROA] (2016 - 2026)

Updated

Intellia Therapeutics (NTLA) posted Return on Assets [ROA] of -49.42% for Q2 2026, up 0.79 percentage points from -50.21% a year earlier but down 0.08 percentage points from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025, Intellia Therapeutics' Return on Assets [ROA] came in at -40.51%, down 1.47 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for five consecutive years, with a five-year change of -13.94 percentage points (FY2020 to FY2025).
  • In prior years, Intellia Therapeutics' Return on Assets [ROA] was -39.04% in FY2024 (-6.04 pp), -33.00% in FY2023 (-1.05 pp), -31.95% in FY2022 (-4.90 pp) and -27.05% in FY2021 (-0.49 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -50.21% in Q2 2025 to a high of -20.28% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in 1 of the last eight quarters, with an average year-over-year change of -6.00 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2023, with a gain of 4.21 percentage points; the weakest was Q3 2022, with a drop of 15.91 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -49.34% (Q1 2026), -46.60% (Q4 2025) and -48.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Intellia Therapeutics 1.57 Bn -171.10 Mn - -48.84%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -48.84%
Jun 30, 2026 -49.71%
Mar 31, 2026 -49.46%
Dec 31, 2025 -46.65%
Sep 30, 2025 -49.13%
Jun 30, 2025 -50.76%
Mar 31, 2025 -48.13%
Dec 31, 2024 -43.84%
Sep 30, 2024 -43.77%
Jun 30, 2024 -41.47%
Mar 31, 2024 -37.95%
Dec 31, 2023 -37.42%
Sep 30, 2023 -35.58%
Jun 30, 2023 -32.67%
Mar 31, 2023 -28.94%
Dec 31, 2022 -36.78%
Sep 30, 2022 -41.11%
Jun 30, 2022 -35.45%
Mar 31, 2022 -30.16%
Dec 31, 2021 -20.58%
API Access

Intellia Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEY